Korman, N. J., Passeron, T., Gordon, K. B., Okubo, Y., Bagel, J., Sofen, H., Warren, R. B., Bhatia, N., Spelman, L., Winthrop, K., Hippeli, L., Kisa, R. M., Banerjee, S., & Thaçi, D. (2023). Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, 7(2), s119. https://doi.org/10.25251/skin.7.supp.119